Publication

Byline

Singapore Clinical Trial: TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label multicenter, Phase II study to assess the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) vs standard of care in patients with progressive metastatic castrate resistant prostate cancer

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-label... और पढ़ें


Singapore Clinical Trial: A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety,... और पढ़ें


Singapore Clinical Trial: Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics In patients with severe and symptomAtic steNosis of inTracranial internal carotid artery or middle cerebral artery with impaired cerebral vasodilatory reserve- an open-label randomised clinical trial (RADIANT)

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Role of glucagon-like peptide 1 receptor Agonist (GLP1 RA) Dulaglutide on cerebral hemodynamics In p... और पढ़ें


Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the effica... और पढ़ें


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adi... और पढ़ें


Pandemic treaty talks deadlocked, leaving world 'largely unprepared', WHO warned

GENEVA, May 1 -- The World Health Organisation said yesterday that divided member states want up to a year of further negotiations on the missing piece of an international agreement on handling future... और पढ़ें


Prabowo tells TNI commanders to deliver benefits to people

Jakarta, May 1 -- President Prabowo Subianto urged Indonesian National Armed Forces (TNI) unit commanders to deliver tangible benefits to the people, Cabinet Secretary Teddy Indra Wijaya said. Teddy ... और पढ़ें


Imperial Oil Q1 Net Profit Declines; Declares Dividend; Stock Down 5.2%

India, May 1 -- Imperial Oil Ltd. (IMO,IMO.TO) reported on Friday that first-quarter net income declined to C$940 million or C$1.94 per share from C$1.29 billion or C$2.52 per share in the prior-year ... और पढ़ें


Dosa beats global rivals! Indian favourite dosa among world's best pancakes in TasteAtlas 2026 list

India, May 1 -- India's beloved dosa has earned major global bragging rights after featuring prominently in TasteAtlas' May 2026 list of the 50 best pancakes in the World. Known for its crisp texture... और पढ़ें


Presidential jet gifted to Trump by Qatar completes testing, set for summer debut amid questions over foreign donation

WASHINGTON, May 1 -- A Boeing 747 that Qatar gave to President Donald Trump has completed flight testing and is expected to make its debut this summer, the US Air Force said yesterday. The aircraft "... और पढ़ें